Zacks Investment Research on MSN
CORT Files MAA for Relacorilant in Platinum-Resistant Ovarian Cancer
Corcept Therapeutics CORT announced that it has submitted a marketing authorization application (MAA) seeking approval for ...
FARGO, N.D. (Valley News Live) - A 20-year-old college student from the Fargo-Moorhead area is turning her unexpected cancer ...
Ovarian cancer is frequently referred to as a “silent killer,” because it develops secretly and generally isn’t discovered until late. Some women don’t recognize what are in fact the daily ...
Several factors make ovarian cancer particularly challenging to treat. This is largely because the cancer often spreads at a ...
Ovarian cancer is an abnormal growth of cells or tumors in the ovaries. Some forms of ovarian cancer are more aggressive than ...
Preventing relapse of advanced ovarian cancer with PARP inhibitors is now an established strategy. As data from pivotal ...
The new test, called the risk of ovarian cancer algorithm (Roca), calculates a woman’s individual risk based on factors such ...
Beyond medical interventions, diet and lifestyle significantly enhance ovarian cancer recovery and quality of life. A balanced diet, rich in whole foo ...
One study from Canada concluded in 2023 that hairdressing and accountancy, among other jobs, correlated with a higher risk of ovarian cancer.
A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to a preclinical study led by Weill Cornell Medicine investigators. The ...
Before her diagnosis of a rare ovarian cancer in 2011, Betty Cox could be found dancing the night away at the Greenwood Moose ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results